Stopped: The study was stopped because all five participants were lost to follow-up before completing treatment or any assessments, leaving no outcome data available and making continuation of the trial infeasible.
The purpose of this study is to determine the safety and compliance of initial intravenous (IV) antibiotics followed by oral antibiotic therapy following uncomplicated IVDA endocarditis. Endocarditis has a high rate of sickness and death, involves a long hospitalization and a long-term use of IV antibiotics necessitating six (6) weeks of in-patient hospital stay, and comes with a high cost.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
All-cause Mortality at Six (6) Months Post-surgery.
Timeframe: Six months
All-cause Mortality at (12) Months Post-surgery.
Timeframe: One year
Incidence of Recurrent Blood Culture Positive Infection (6 Month)
Timeframe: Six months
Incidence of Recurrent Blood Culture Positive Infection (1 Year)
Timeframe: One year
Incidence of Cardiac Re-operation (6 Month)
Timeframe: Six months
Incidence of Cardiac Re-operation (1 Year)
Timeframe: One year